Cencora (NYSE:COR – Get Free Report) and AdaptHealth (NASDAQ:AHCO – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.
Risk & Volatility
Cencora has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500.
Institutional & Insider Ownership
97.5% of Cencora shares are held by institutional investors. Comparatively, 82.7% of AdaptHealth shares are held by institutional investors. 0.4% of Cencora shares are held by insiders. Comparatively, 1.9% of AdaptHealth shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares Cencora and AdaptHealth”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cencora | $337.40 billion | 0.19 | $3.48 billion | $17.92 | 18.92 |
| AdaptHealth | $3.24 billion | 0.30 | -$70.79 million | ($3.00) | -2.40 |
Cencora has higher revenue and earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current ratings and recommmendations for Cencora and AdaptHealth, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cencora | 0 | 3 | 13 | 0 | 2.81 |
| AdaptHealth | 1 | 1 | 7 | 0 | 2.67 |
Cencora presently has a consensus price target of $381.00, indicating a potential upside of 12.37%. AdaptHealth has a consensus price target of $9.43, indicating a potential upside of 30.84%. Given AdaptHealth’s higher probable upside, analysts clearly believe AdaptHealth is more favorable than Cencora.
Profitability
This table compares Cencora and AdaptHealth’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cencora | 1.03% | 110.72% | 4.22% |
| AdaptHealth | -12.90% | -0.27% | -0.09% |
Summary
Cencora beats AdaptHealth on 9 of the 13 factors compared between the two stocks.
About Cencora
Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical services company that connects pharmaceutical manufacturers with healthcare providers. Its core business includes sourcing and distributing medicines and other healthcare products to pharmacies, hospitals, health systems and other care providers. The company also provides services supporting specialty pharmaceuticals, including logistics, consulting and solutions for manufacturers and healthcare organizations. These services help manage the handling and delivery of complex medicines and support access to treatments.
About AdaptHealth
AdaptHealth provides home medical equipment, supplies and related services to patients managing chronic conditions and recovering from illness or injury. Its offerings include oxygen and other respiratory equipment, sleep-therapy devices such as CPAP machines, and diabetes supplies, including continuous glucose monitoring products. The company also provides equipment and support for other care needs at home, working with patients, clinicians, hospitals and health plans to help coordinate access to prescribed products and services.
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
